Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Pegasus Laboratories Expands Pensacola, Florida, Operations

10/04/2025
Pegasus Laboratories, a manufacturer of veterinary pharmaceuticals, has expanded its operations in Pensacola, Florida. The up to $45 million project is expected to create approximately 70 jobs.

The company’s new 172,000-square-foot facility, located at the Ellyson Industrial Park, will feature increased manufacturing capacity and laboratory spaces.

“By expanding our operations in Pensacola, we’re not just increasing our production capacity, but we’re also investing in the future of our employees and the communities we serve,” said Steve Clifford, CEO of Pegasus Laboratories. “Our growth here is a direct result of the support from the FloridaWest Economic Development Alliance, Triumph Gulf Coast, and local economic development partners who understand the importance of sustainable, high-tech jobs.”

The project is being supported by a $2.5 million grant from Triumph Gulf Coast to the Pensacola–Escambia Promotion and Development Commission (PEDC) for the acquisition of the facility.

“The funding of this renovated facility is an example of how targeted public investment can drive meaningful economic impact,” noted David Bear, President of the FloridaWest board of directors. “We are thrilled to see Pegasus Laboratories continue to grow in Pensacola, creating valuable, high-skilled jobs in the life sciences sector.”

Pegasus Laboratories, a subsidiary of PBI-Gordon Companies, distributes products under its own brands and offers contract development and manufacturing services for other animal health companies. The company’s products are used by veterinarians to treat a range of chronic conditions in pets.

Exclusive Research